| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.35 | 4e-26 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-15 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.33 | 6e-10 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.21 | 9e-06 |